The University of Global Health Equity aims to provide the tools and technology to develop the skills students need to improve fragile health systems.

In the 1910s, the American Medical Association fought quackery promoted in pamphlets for drugs and treatments for everything from teething to epilepsy.

Minimizing and managing risks of ENMs means considering whether and when existing legal frameworks offer sufficient protection.

Nanoscale products pose ethical, legal, and policy challenges to governing the use of products that integrate multiple mechanisms of therapeutic action.

Global health outreach programs can risk benefitting students from resource-rich areas of the world more than the patients in resource-poor areas of the world. This month’s episode of Ethics Talk explores an alternative to academic health center-based health outreach programs.

Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions.

Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation.

Little claims data exists upon which to make informed decisions about loss control or to draw upon when developing risk mitigation strategies.

When a patient is incompetent and unrepresented, alternative strategies must be implemented to document and try to rectify an error.

Guidelines are needed to help ensure that trainee, institutional, and faculty engagement in global health is ethically appropriate and mutually beneficial for all involved.